InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Monday, 02/09/2015 2:07:40 PM

Monday, February 09, 2015 2:07:40 PM

Post# of 80868
if Dymatize is worth approx $400 million with less sales than Musclepharm....then explain to me how Musclepharm should be worth 25% of that because it lacks own manufacturing for most of it's products?

Having all manufacturing centered in America might not even be the best solution anylonger with a strengthening US dollar....Could be that manufacturing in Canada is cheaper, or manufacturing in China or Brazil would be cheaper and better suit the import restrictions that exist in these markets.
For a line like the Iron line, I'm sure Musclepharm could get away with producing it in China....while it for the core MP line, probably would be better of manufacturing it in America.

The recent lawsuit may strengthen Musclepharm's quality control of it's manufacturing through third parties...which I only see as a positive as Musclepharm potentially expands with manufacturing abroad.